Paloma Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Paloma Pharmaceuticals Ownership

Who owns Paloma Pharmaceuticals?

Paloma Pharmaceuticals is owned by RestorGenex. It was acquired on April 1, 2014.

Paloma Pharmaceuticals Business Overview

Where is Paloma Pharmaceuticals headquartered?

Paloma Pharmaceuticals is headquartered in Jamaica Plain, Massachusetts.

What sector is Paloma Pharmaceuticals in?

Paloma Pharmaceuticals is a life science company.

When was Paloma Pharmaceuticals founded?

Paloma Pharmaceuticals was founded in 2005.

Life Science M&A Summary in 2014

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2014. The largest life science acquisition in 2014 was InterMune - which was acquired by Roche Holding AG for $8.3B.

Join Mergr to view all 237 acquisitions of life science companies in 2014, including 22 acquisitions by private equity firms, and 215 by strategics.

Paloma Pharmaceuticals, Inc.

37 Neillian Crescent,
Jamaica Plain, Massachusetts 02130
United States,
9617) 407-6314
www.palomapharma.com

Paloma Pharmaceuticals, Inc. has developed a non-steroidal, synthetic, small molecule drug library through computational design, synthetic and medicinal chemistry, resulting in a family of anti-tumor agents, "Palomids".


 Subscribe to unlock this and 205,946
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 201K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 79K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.